Stereotaxis Capex To Revenue vs Days Sales Outstanding Analysis

STXS Stock

USD 2.39 0.16 7.17%

Stereotaxis financial indicator trend analysis is much more than just breaking down Stereotaxis prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Stereotaxis is a good investment. Please check the relationship between Stereotaxis Capex To Revenue and its Days Sales Outstanding accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stereotaxis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Stereotaxis Stock please use our How to Invest in Stereotaxis guide.

Capex To Revenue vs Days Sales Outstanding

Capex To Revenue vs Days Sales Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Stereotaxis Capex To Revenue account and Days Sales Outstanding. At this time, the significance of the direction appears to have totally related.

The correlation between Stereotaxis' Capex To Revenue and Days Sales Outstanding is 1.0. Overlapping area represents the amount of variation of Capex To Revenue that can explain the historical movement of Days Sales Outstanding in the same time period over historical financial statements of Stereotaxis, assuming nothing else is changed. The correlation between historical values of Stereotaxis' Capex To Revenue and Days Sales Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Revenue of Stereotaxis are associated (or correlated) with its Days Sales Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Sales Outstanding has no effect on the direction of Capex To Revenue i.e., Stereotaxis' Capex To Revenue and Days Sales Outstanding go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Days Sales Outstanding

Most indicators from Stereotaxis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Stereotaxis current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stereotaxis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy Stereotaxis Stock please use our How to Invest in Stereotaxis guide.Selling General Administrative is likely to drop to about 13.3 M in 2024. Issuance Of Capital Stock is likely to drop to about 110.2 K in 2024

	2021	2022	2023	2024 (projected)
Total Revenue	35.0M	28.1M	26.8M	34.4M
Depreciation And Amortization	105.7K	429K	595K	961.3K

Total Revenue Depreciation And Amortization

Stereotaxis fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Accounts Payable	Cash	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Other Current Assets	Property Plant And Equipment Gross
Total Assets		0.75	-0.23	0.2	-0.16	-0.09	0.62	-0.05	-0.47	-0.18	-0.12	-0.46	-0.25	0.24	0.63	0.0	-0.43	0.44	0.7	-0.24	0.84	0.03	0.67	0.36	0.59	0.59
Total Stockholder Equity	0.75		-0.03	0.42	0.22	0.29	0.74	-0.52	-0.39	-0.77	-0.64	-0.55	-0.73	0.17	0.49	-0.55	-0.84	-0.14	0.81	-0.65	0.94	-0.56	0.64	-0.06	0.03	0.49
Retained Earnings	-0.23	-0.03		0.74	0.92	0.91	-0.64	-0.06	0.03	-0.2	0.11	-0.09	-0.07	-0.57	-0.41	-0.55	0.0	-0.14	0.11	0.13	0.06	-0.22	-0.61	-0.26	-0.15	-0.45
Non Current Assets Total	0.2	0.42	0.74		0.86	0.86	-0.08	-0.17	-0.24	-0.45	-0.2	-0.33	-0.39	-0.16	0.26	-0.6	-0.27	0.04	0.32	-0.21	0.41	-0.42	-0.1	0.08	-0.1	0.2
Non Currrent Assets Other	-0.16	0.22	0.92	0.86		0.99	-0.35	-0.25	-0.01	-0.49	-0.22	-0.18	-0.36	-0.43	-0.21	-0.74	-0.28	-0.31	0.26	-0.15	0.23	-0.53	-0.4	-0.26	-0.35	-0.2
Other Assets	-0.09	0.29	0.91	0.86	0.99		-0.31	-0.29	-0.04	-0.52	-0.25	-0.2	-0.39	-0.43	-0.21	-0.77	-0.33	-0.32	0.32	-0.18	0.31	-0.56	-0.37	-0.27	-0.33	-0.21
Common Stock Shares Outstanding	0.62	0.74	-0.64	-0.08	-0.35	-0.31		-0.4	-0.24	-0.48	-0.59	-0.37	-0.52	0.5	0.72	-0.09	-0.62	-0.05	0.48	-0.65	0.58	-0.32	0.92	0.14	0.05	0.78
Non Current Liabilities Total	-0.05	-0.52	-0.06	-0.17	-0.25	-0.29	-0.4		0.02	0.73	0.87	-0.19	0.31	0.16	-0.02	0.53	0.76	0.49	-0.38	0.93	-0.41	0.72	-0.28	0.47	0.41	-0.07
Other Stockholder Equity	-0.47	-0.39	0.03	-0.24	-0.01	-0.04	-0.24	0.02		0.14	0.13	0.18	0.17	-0.47	-0.36	0.09	0.36	-0.34	-0.47	0.17	-0.44	0.05	-0.19	0.03	-0.35	-0.23
Total Liab	-0.18	-0.77	-0.2	-0.45	-0.49	-0.52	-0.48	0.73	0.14		0.83	0.39	0.86	-0.06	-0.1	0.82	0.83	0.63	-0.54	0.73	-0.59	0.88	-0.28	0.39	0.53	-0.13
Short Long Term Debt Total	-0.12	-0.64	0.11	-0.2	-0.22	-0.25	-0.59	0.87	0.13	0.83		-0.08	0.57	-0.08	-0.23	0.56	0.85	0.57	-0.41	0.92	-0.46	0.85	-0.37	0.35	0.52	-0.28
Other Current Liab	-0.46	-0.55	-0.09	-0.33	-0.18	-0.2	-0.37	-0.19	0.18	0.39	-0.08		0.69	-0.31	-0.31	0.33	0.2	0.01	-0.41	-0.07	-0.47	0.09	-0.4	-0.15	-0.1	-0.3
Total Current Liabilities	-0.25	-0.73	-0.07	-0.39	-0.36	-0.39	-0.52	0.31	0.17	0.86	0.57	0.69		-0.27	-0.22	0.7	0.65	0.53	-0.49	0.4	-0.54	0.68	-0.33	0.19	0.42	-0.25
Other Liab	0.24	0.17	-0.57	-0.16	-0.43	-0.43	0.5	0.16	-0.47	-0.06	-0.08	-0.31	-0.27		0.51	0.21	-0.05	0.11	-0.06	-0.08	0.04	-0.06	0.41	0.36	-0.05	0.45
Property Plant And Equipment Net	0.63	0.49	-0.41	0.26	-0.21	-0.21	0.72	-0.02	-0.36	-0.1	-0.23	-0.31	-0.22	0.51		0.14	-0.2	0.46	0.22	-0.35	0.39	0.0	0.74	0.51	0.31	0.96
Current Deferred Revenue	0.0	-0.55	-0.55	-0.6	-0.74	-0.77	-0.09	0.53	0.09	0.82	0.56	0.33	0.7	0.21	0.14		0.66	0.57	-0.53	0.45	-0.48	0.79	-0.01	0.54	0.52	0.1
Net Debt	-0.43	-0.84	0.0	-0.27	-0.28	-0.33	-0.62	0.76	0.36	0.83	0.85	0.2	0.65	-0.05	-0.2	0.66		0.42	-0.82	0.81	-0.79	0.77	-0.46	0.37	0.26	-0.27
Accounts Payable	0.44	-0.14	-0.14	0.04	-0.31	-0.32	-0.05	0.49	-0.34	0.63	0.57	0.01	0.53	0.11	0.46	0.57	0.42		-0.04	0.35	0.01	0.69	0.22	0.57	0.78	0.35
Cash	0.7	0.81	0.11	0.32	0.26	0.32	0.48	-0.38	-0.47	-0.54	-0.41	-0.41	-0.49	-0.06	0.22	-0.53	-0.82	-0.04		-0.44	0.91	-0.39	0.47	-0.21	0.19	0.28
Long Term Debt	-0.24	-0.65	0.13	-0.21	-0.15	-0.18	-0.65	0.93	0.17	0.73	0.92	-0.07	0.4	-0.08	-0.35	0.45	0.81	0.35	-0.44		-0.51	0.71	-0.52	0.28	0.32	-0.4
Cash And Short Term Investments	0.84	0.94	0.06	0.41	0.23	0.31	0.58	-0.41	-0.44	-0.59	-0.46	-0.47	-0.54	0.04	0.39	-0.48	-0.79	0.01	0.91	-0.51		-0.42	0.55	-0.04	0.22	0.39
Net Receivables	0.03	-0.56	-0.22	-0.42	-0.53	-0.56	-0.32	0.72	0.05	0.88	0.85	0.09	0.68	-0.06	0.0	0.79	0.77	0.69	-0.39	0.71	-0.42		-0.11	0.29	0.75	-0.07
Common Stock Total Equity	0.67	0.64	-0.61	-0.1	-0.4	-0.37	0.92	-0.28	-0.19	-0.28	-0.37	-0.4	-0.33	0.41	0.74	-0.01	-0.46	0.22	0.47	-0.52	0.55	-0.11		0.2	0.21	0.8
Inventory	0.36	-0.06	-0.26	0.08	-0.26	-0.27	0.14	0.47	0.03	0.39	0.35	-0.15	0.19	0.36	0.51	0.54	0.37	0.57	-0.21	0.28	-0.04	0.29	0.2		0.3	0.49
Other Current Assets	0.59	0.03	-0.15	-0.1	-0.35	-0.33	0.05	0.41	-0.35	0.53	0.52	-0.1	0.42	-0.05	0.31	0.52	0.26	0.78	0.19	0.32	0.22	0.75	0.21	0.3		0.24
Property Plant And Equipment Gross	0.59	0.49	-0.45	0.2	-0.2	-0.21	0.78	-0.07	-0.23	-0.13	-0.28	-0.3	-0.25	0.45	0.96	0.1	-0.27	0.35	0.28	-0.4	0.39	-0.07	0.8	0.49	0.24

Click cells to compare fundamentals

Stereotaxis Account Relationship Matchups

Stereotaxis fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	43.6M	55.5M	61.0M	53.4M	41.9M	33.6M
Total Stockholder Equity	28.5M	40.2M	39.4M	31.9M	16.3M	10.1M
Retained Earnings	(481.3M)	(488.0M)	(498.7M)	(517.0M)	(537.7M)	(564.6M)
Non Current Assets Total	4.8M	503.6K	9.6M	10.2M	8.6M	4.7M
Non Currrent Assets Other	218.1K	308.5K	278.2K	208K	356K	338.2K
Other Assets	218.1K	2.5M	1.2M	952K	1.0	0.95
Common Stock Shares Outstanding	63.1M	72.7M	75.6M	76.1M	80.7M	84.7M
Liabilities And Stockholders Equity	43.6M	55.5M	61.0M	53.4M	41.9M	33.6M
Non Current Liabilities Total	2.9M	1.7M	8.3M	7.2M	6.7M	9.6M
Other Stockholder Equity	504.0M	522.5M	(5.0B)	543.2M	553.9M	581.6M
Total Liab	15.1M	15.2M	21.6M	21.5M	20.0M	32.1M
Other Current Liab	2.7M	3.0M	2.4M	2.9M	3.0M	5.8M
Total Current Liabilities	12.2M	13.6M	13.3M	14.3M	13.2M	17.1M
Other Liab	809.8K	680.1K	2.5M	1.7M	2.0M	1.1M
Property Plant And Equipment Net	4.5M	195.1K	8.4M	9.2M	8.3M	8.7M
Current Deferred Revenue	5.1M	5.3M	6.3M	7.3M	6.7M	6.9M
Net Debt	(25.8M)	(39.5M)	(32.6M)	(2.7M)	(14.3M)	(13.6M)
Accounts Payable	2.1M	1.6M	4.2M	3.3M	3.2M	2.8M
Cash	30.2M	43.9M	38.7M	8.6M	19.8M	20.7M
Cash And Short Term Investments	30.2M	43.9M	38.7M	28.4M	19.8M	18.2M
Net Receivables	5.3M	3.5M	5.4M	5.1M	3.8M	5.9M
Common Stock Total Equity	68.5K	73.7K	74.6K	75K	86.3K	90.6K
Inventory	1.8M	3.3M	4.4M	7.9M	8.4M	4.3M
Other Current Assets	1.5M	2.0M	2.8M	1.9M	1.2M	1.7M
Property Plant And Equipment Gross	4.5M	2.4M	8.4M	9.2M	12.2M	12.8M
Total Current Assets	38.8M	55.0M	51.4M	43.2M	33.3M	30.2M
Common Stock	68.5K	73.7K	74.6K	75K	81K	43.9K
Property Plant Equipment	250.4K	195.1K	8.4M	3.8M	3.4M	2.2M
Net Tangible Assets	28.5M	40.2M	33.8M	31.9M	36.7M	38.5M
Retained Earnings Total Equity	(481.3M)	(488.0M)	(498.7M)	(517.0M)	(465.3M)	(488.5M)
Capital Surpluse	504.2M	522.7M	532.6M	543.4M	625.0M	508.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Stereotaxis Stock Analysis

When running Stereotaxis' price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC